Best Practice for Late Stage Funding - Kameel Farag, Hari Pujar, Randy Berholtz
Release Date:
Our expert panel of C-level executives and board members reveal their tips tricks for successful late stage funding rounds. Great insight from: Hari Pujar - Operating Partner at Flagship Therapeutics and COO at Tessera Therapeutics Randy Berholtz - Chair and Chief Executive Officer Chair and Chief Executive Officer - Rancho Santa Fe Bio, Inc. Kameel Farag - CFO Aspen NeuroScience Hosted by Jared Green and Alex Cooke from Phase 3 Search www.ph3.bio
Best Practice for Late Stage Funding - Kameel Farag, Hari Pujar, Randy Berholtz